Rchr
J-GLOBAL ID:201401051154453867   Update date: Jan. 30, 2024

Mino Takashi

ミノ タカシ | Mino Takashi
Affiliation and department:
Research field  (4): Cell biology ,  Molecular biology ,  Medical biochemistry ,  Immunology
Research keywords  (5): Cytokine ,  Translation ,  RNA degradation ,  Post-transcriptional regulation ,  Immunology
Research theme for competitive and other funds  (4):
  • 2018 - 2023 Analysis of immune regulatory mechanisms mediated by mRNA metabolism
  • 2019 - 2022 Study of mRNA translation in immune system
  • 2016 - 2019 Study of UPF1-mediated mRNA regulation in immune system
  • 2013 - 2015 Analysis of posttranscriptional mechanisms of Regnase-1-mediated mRNA decay in innate immune system
Papers (36):
  • Takuya Uehata, Shinnosuke Yamada, Daisuke Ori, Alexis Vandenbon, Amir Giladi, Adam Jelinski, Yasuhiro Murakawa, Hitomi Watanabe, Kazuhiro Takeuchi, Kazunori Toratani, et al. Regulation of lymphoid-myeloid lineage bias through Regnase-1/3-mediated control of Nfkbiz. Blood. 2023
  • Ai Yaku, Tadakatsu Inagaki, Ryotaro Asano, Makoto Okazawa, Hiroyoshi Mori, Ayuko Sato, Fabian Hia, Takeshi Masaki, Yusuke Manabe, Tomohiko Ishibashi, et al. Regnase-1 Prevents Pulmonary Arterial Hypertension Through mRNA Degradation of Interleukin-6 and Platelet-Derived Growth Factor in Alveolar Macrophages. Circulation. 2022. 101161CIRCULATIONAHA122059435
  • Kotaro Akaki, Takashi Mino, Osamu Takeuchi. DSP-crosslinking and Immunoprecipitation to Isolate Weak Protein Complex. BIO-PROTOCOL. 2022. 12. 15
  • Ka Man Tse, Alexis Vandenbon, Xiaotong Cui, Takashi Mino, Takuya Uehata, Keiko Yasuda, Ayuko Sato, Tohru Tsujimura, Fabian Hia, Masanori Yoshinaga, et al. Enhancement of Regnase-1 expression with stem loop-targeting antisense oligonucleotides alleviates inflammatory diseases. Science translational medicine. 2022. 14. 644. eabo2137
  • Yee Kien Chong, Sarang Tartey, Yuki Yoshikawa, Koshi Imami, Songling Li, Masanori Yoshinaga, Ai Hirabayashi, Guohao Liu, Alexis Vandenbon, Fabian Hia, et al. Cyclin J-CDK complexes limit innate immune responses by reducing proinflammatory changes in macrophage metabolism. Science signaling. 2022. 15. 729. eabm5011
more...
MISC (7):
  • 吉永正憲, 三野享史, BASSIK Michael C, 竹内理. 鉄代謝を制御する転写後調節機構の解明. 日本RNA学会年会要旨集. 2018. 20th
  • 吉永正憲, 三野享史, 竹内理. Regnase-1は鉄代謝関連のmRNAを分解することで鉄恒常性を維持する. 日本分子生物学会年会プログラム・要旨集(Web). 2018. 41st
  • Yoshinari Nakatsuka, Takashi Mino, Masanori Yoshinaga, Takuya Uehata, Atsuyasu Sato, Tomohiro Handa, Kazuo Chin, Toyohiro Hirai Hirai, Osamu Takeuchi. Pulmonary Regnase-1 functions as a posttranscriptional switch in anti-bacterial immunity. CYTOKINE. 2017. 100. 39-39
  • 吉永正憲, 三野享史, 竹内理. Regnase-1は鉄代謝関連のmRNAを分解することで鉄恒常性を維持する. 日本生化学会大会(Web). 2017. 90th
  • 吉永正憲, 三野享史, 竹内理. Regnase-1は鉄代謝関連のmRNAを分解することで鉄恒常性を維持する. 日本RNA学会年会要旨集. 2017. 19th
more...
Patents (1):
  • IMMUNOSTIMULANTS
Education (3):
  • 2006 - 2009 Kyoto University Graduate School of Engineering Department of Synthetic Chemistry and Biological Chemistry
  • 2004 - 2006 Kyoto University Graduate School of Engineering Department of Synthetic Chemistry and Biological Chemistry
  • 2002 - 2004 Kyoto University Faculty of Engineering School of Industrial Chemistry
Professional career (1):
  • 博士(工学) (京都大学)
Work history (6):
  • 2019/04 - 現在 Kyoto University Graduate School of Medicine Assistant Professor
  • 2016/10 - 2019/03 Kyoto University Institute for Frontier Life and Medical Sciences Assistant Professor
  • 2012/06 - 2016/09 Kyoto University Institute for Virus Research Assistant Professor
  • 2010/04 - 2012/06 Osaka University WPI Immunology Frontier Research Center Specially Appointed Researcher
  • 2009/04 - 2010/03 The University of California, San Diego School of Medicine Postdoctoral Fellow
Show all
Awards (3):
  • 2021/12 - 日本免疫学会 第16回(2021年) 日本免疫学会 研究奨励賞
  • 2020/02 - 日本免疫学会 第48回日本免疫学会学術集会 ベストプレゼンテーション賞
  • 2007/05 - 日本化学会 日本化学会第87春季年会(2007) 学生講演賞
Association Membership(s) (2):
日本RNA学会 ,  日本免疫学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page